Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

Christian Luscher, a neuroscientist at the University of Geneva, presenting on addiction at the Allen Institute. (Allen Insitute Photo / Erik Dinnel) Christian Luscher has spent years trying to figure ...

Nicotine addiction remains one of the most persistent public health challenges worldwide, driven by changes in the brain that ...

Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.

Explore the connections between the world of neuroscience and nuances of substance use disorders with our inaugural episode of In Such a Place. We’ll speak with Dr. Anna Radke, a leading expert in the ...

Some researchers argue that the roles of social environment and personal choice have to be considered in order to make progress in treating people addicted to drugs. By Jan Hoffman The message ...

Ms. Szalavitz is a contributing Opinion writer who covers addiction and public policy. In August 2021, while promoting her new book “Dopamine Nation,” the Stanford psychiatrist Anna Lembke discussed ...

For decades, Americans have been told a simple story about addiction: taking drugs damages the brain—and the earlier in life children start using substances, the more likely they are to progress ...

Editor's Note: The graphic at the end of this segment used imprecise terminology. The Legal Action Center survey referred to “substance use disorder.” This week, we are reporting on some promising ...

Excessive gaming disrupts teens' sleep, school, and social lives. An expert from Stanford's Youth Recovery Clinic shares ...

Share on Pinterest A growing body of evidence suggests that GLP-1 drugs prescribed for obesity and diabetes could also help treat addiction. FreshSplash/Getty Images GLP-1 drugs like Ozempic and ...